Litcius/Paper detail

Clopidogrel versus ticagrelor or prasugrel in patients aged 70 years or older with non-ST-elevation acute coronary syndrome (POPular AGE): the randomised, open-label, non-inferiority trial

Marieke E. Gimbel, Khalid Qaderdan, Laura M. Willemsen, Rik Hermanides, Thomas O. Bergmeijer, Evelyn de Vrey, Ton A.C.M. Heestermans, Melvyn Tjon Joe Gin, Reinier A. Waalewijn, Sjoerd H. Hofma, Frank den Hartog, J. Wouter Jukema, Clemens von Birgelen, Michiel Voskuil, Johannes C. Kelder, Vera H.M. Deneer, Jurriën M. ten Berg

2020The Lancet350 citationsDOIOpen Access PDF

Topics & Concepts

PrasugrelTicagrelorMedicineClopidogrelAcute coronary syndromeMyocardial infarctionInternal medicineRandomized controlled trialCardiologyAntiplatelet Therapy and Cardiovascular DiseasesAcute Myocardial Infarction ResearchInflammatory Biomarkers in Disease Prognosis
Clopidogrel versus ticagrelor or prasugrel in patients aged 70 years or older with non-ST-elevation acute coronary syndrome (POPular AGE): the randomised, open-label, non-inferiority trial | Litcius